lino Biotech was incorporated in Zürich, Switzerland, in March 2020 after 10 years of research as spin-out from Roche Diagnostics. We have developed a reagent-free method for measuring molecular interactions in living cells or crude biological samples called focal Molography. With our first products, we aim to lower the cost of drug discovery and cell and gene therapies and make them more cost effective and accessible for a broader patient population by offering access to a unique analytical technology to optimize production processes at highest quality level. Our team consists of highly qualified experts with different backgrounds in Biochemistry, Biophysics, Biomedical Engineering, Software Engineering and Business Development, all with the same goal.